A type of immune cell that contributes to inflammatory bowel disease exists in two forms, 'good' and 'bad'. A new Crick-led study in Immunity has characterised these distinct populations, which could help scientists to develop treatments targeting inflammation while preserving healthy gut function.
* This article was originally published here
